CN101856424A - Chinese medicament for treating chronic pharyngitis - Google Patents
Chinese medicament for treating chronic pharyngitis Download PDFInfo
- Publication number
- CN101856424A CN101856424A CN200910044240A CN200910044240A CN101856424A CN 101856424 A CN101856424 A CN 101856424A CN 200910044240 A CN200910044240 A CN 200910044240A CN 200910044240 A CN200910044240 A CN 200910044240A CN 101856424 A CN101856424 A CN 101856424A
- Authority
- CN
- China
- Prior art keywords
- chronic pharyngitis
- medicine
- stasis
- chinese medicament
- people
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 201000007100 Pharyngitis Diseases 0.000 title claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 8
- 235000008434 ginseng Nutrition 0.000 claims abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 241000208340 Araliaceae Species 0.000 claims description 7
- 241000180649 Panax notoginseng Species 0.000 claims description 7
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000007963 capsule composition Substances 0.000 claims 1
- 239000004518 granules dosage form Substances 0.000 claims 1
- 239000012669 liquid formulation Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 10
- 210000000952 spleen Anatomy 0.000 abstract description 9
- 230000001047 pyretic effect Effects 0.000 abstract description 7
- 230000001988 toxicity Effects 0.000 abstract description 7
- 231100000419 toxicity Toxicity 0.000 abstract description 7
- 210000004072 lung Anatomy 0.000 abstract description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 4
- 230000006870 function Effects 0.000 abstract description 4
- 208000026435 phlegm Diseases 0.000 abstract description 4
- 244000131316 Panax pseudoginseng Species 0.000 abstract 2
- 239000003053 toxin Substances 0.000 abstract 2
- 231100000765 toxin Toxicity 0.000 abstract 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000218206 Ranunculus Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 241000293861 Scrophularia nodosa Species 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000003800 pharynx Anatomy 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 239000008187 granular material Substances 0.000 description 8
- 210000002751 lymph Anatomy 0.000 description 8
- 230000028327 secretion Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 206010070245 Foreign body Diseases 0.000 description 4
- 208000027744 congestion Diseases 0.000 description 4
- 230000008034 disappearance Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 206010020880 Hypertrophy Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000006735 deficit Effects 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000016150 acute pharyngitis Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- AQNQGBUEVCAVML-UHFFFAOYSA-N oxazepane Chemical compound C1CCNOCC1 AQNQGBUEVCAVML-UHFFFAOYSA-N 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating chronic pharyngitis, which consists of 415 to 450 parts of buttercup root, 415 to 450 parts of figwort root, 498 to 665 parts of pseudo-ginseng and 208 to 400 parts of ginseng fibrous root. The functions of the Chinese medicament include tonifying qi, treating yin, detoxifying, reducing phlegm and dissipating stagnation and is mainly used for treating chronic pharyngitis with symptoms of toxin stasis, pyretic toxicity stasis in collaterals, and weakness of spleen and lung. In clinic, the Chinese medicament has remarkable treatment effect on hronic pharyngitis with symptoms of toxin stasis, pyretic toxicity stasis in collaterals, and weakness of spleen and lung. According to the observation of 30 people with chronic pharyngitis, the Chinese medicament can cure 28 people of chronic pharyngitis and basically cure 2 people of chronic pharyngitis in 28 people in 7 to 28 days, the total effective rate is 100 percent, toxic and side effects are not produced, and the medicament administration is safe.
Description
Technical field
The invention belongs to the Chinese medicine of treatment chronic pharyngitis disease.
Background technology
Chronic pharyngolaryngitis belongs to the traditional Chinese medical science " sore throat " category.At present, the Chinese medicine primary disease, the overwhelming majority is to adopt methods such as YIN nourishing, heat clearing away with the deficiency of YIN, hyperactivity of fire argument, method of treatment more.Along with the widespread usage of cold and cool medicine, yang deficiency chronic pharyngitis case is in rising trend.And because of chronic pharyngolaryngitis shows effect repeatedly, it is empty to cause patient's spleen, lung qi to lose, and stasis of blood poison is tied mutually, pyretic toxicity stagnates, and network is serious, adopts conventional YIN nourishing, clearing away heat method treatment, but the respite state of an illness, but often must not effect a radical cure.Doctor trained in Western medicine adopts antibiotics, anti-inflammatory agent controlling microbial to infect and inflammation more, or use iodine preparation, vitamin to improve symptom or be used in and disturb extract for treating, use external treatmenies such as laser, radio frequency in case of necessity, though sense makes moderate progress to foreign body in pharynx, but because of reasons such as the glandular secretion that destroyed mucosa and scar contractures, tend to bring dry pharynx and pharyngalgia is increased the weight of, doctor trained in Western medicine, western medicine primary disease, the uncertain therapeutic efficacy that has is cut.Side effect is often arranged.What have costs an arm and a leg, owing to cure the symptoms, not the disease, more is difficult to radical cure.
Its function of the present invention's " pharynx refreshing granule " slowly is QI invigorating, YIN nourishing, detoxify, reduce phlegm, eliminating stagnation.Cure mainly the stasis of blood poison knot, the stagnant network of pyretic toxicity mutually, the chronic pharyngitis of spleen, insufficiency of lung-QI type.This temperature, the medicine of a cold nature also combine with, detoxifcation, blood stasis dispelling, and with eliminating stagnation, detumescence, YIN nourishing, antidote are principal agent-Radix Ranunculi Ternati, Radix Scrophulariae, reuse the therapy of hemostasis by invigorating QI, stasis-resolving hemostatic-Radix Notoginseng, Leptoradix Ginseng, make and take hardship, tremble with fear, cathartic and non-impairment of YIN; In heat clearing away, pathogenic fire purging, removing heat from blood, make spleen, insufficiency of lung-QI be trained benefit, treatment is got twice the result with half the effort.Therefore, the present invention, its reasonable recipe, novelty, the cure rate height has no side effect.In the Chinese patent medicine of existing treatment chronic pharyngitis, do not see as yet.
Summary of the invention
The purpose of this invention is to provide that the effect of a kind of treatment chronic pharyngitis is obvious, side effect is little, low price, the cure rate height has QI invigorating, YIN nourishing, detoxifies, reduces phlegm, the eliminating stagnation function.Cure mainly the stasis of blood poison knot, the stagnant network of pyretic toxicity mutually, the Chinese patent medicine of spleen, insufficiency of lung-QI type.
Chinese medicine of the present invention is made up of following medicine and weight ratio: Radix Ranunculi Ternati 415-450 Radix Scrophulariae 415-450 Radix Notoginseng 498-665 Leptoradix Ginseng 208-400.And can by this basic side suitably plus-minus be formulated into and have the medicine that above-mentioned functions cures mainly.Its etiology and pathogenesis of chronic pharyngitis is: often deficient because of internal organs, consumption impairment of YIN branch, hyperactivity of deficient fire causes in throat.Or because of acute pharyngitis due to wind-heat shows effect repeatedly, surplus evil delay or dust, foul smell stimulate, and the hobby tobacco and wine are pungent, and impairment caused by overstrain excessively waits and causes.Deficiency of lung-YIN is deficiency of body fluid then, and throat loses in moistening foster, and furthermore asthenic fire is followed through last inflammation; Deficiency of the kidney yin, network is in lung on the passages through which vital energy circulates of kidney, and deficiency of the kidney yin whenever causes the also deficiency of YIN of lung, and hyperactivity of deficient fire causes inflammation of the throat then.Steam on the asthenic fire in addition, bright Tianjin becomes expectorant, venation numbness resistance in addition, and disorder of QI movement causes stagnation of QI expectorant and coagulates phlegm-fire pent-up.Symptom is usually expressed as pharyngeal chronic congestion, lateral pharyngeal band enlargement, retropharynx lymph foilicie hyperplasia, foreign body in pharynx sense.Multiple chronic disease such as anemia, constipation, lower respiratory tract chronic inflammatory disease, cardiovascular disease etc. cause that blood stasis sexually revises, and immunity of organisms descends.Therefore, stasis of blood poison mutually stagnate network, network of knot, pyretic toxicity cease that to become to amass be the main etiology and pathogenesis that runs through primary disease; Stasis of blood poison does not loose, spleen, insufficiency of lung-QI are primary disease protracted course of disease, state of an illness cruxs repeatedly.Radix Ranunculi Ternati in the side, sweet in the mouth, suffering, warm in nature: eliminating stagnation, detumescence; Radix Scrophulariae, sweet, bitter, salty, be slightly cold, the removing heat from blood YIN nourishing, eliminating fire and detoxication, the two is monarch altogether; Radix Notoginseng is a minister: sweet, little hardship, temperature: dissipating blood stasis hemostasis, subduing swelling and relieving pain, principal drug assistance blood stasis dispelling, eliminating stagnation, detoxifcation; The Leptoradix Ginseng: nourishing qi to stop, promoting the production of body fluid wets one's whistle, and makes spleen, insufficiency of lung-QI be trained benefit, is adjuvant drug.
Chinese medicine of the present invention can be made granule, also can make tablet, capsule, pill, oral liquid, mixture and other dosage form.
By to 30 routine stasis of bloods poison knot, the pyretic toxicity network that stagnates mutually, chronic pharyngitis patient's clinical observation of spleen, insufficiency of lung-QI type, its course of disease is generally 1-3 from several months to 7 year, takes the treatment of multiple Chinese and western drugs and method mostly, but still outbreak repeatedly, protracted course of disease.Take " pharynx refreshing granule " slowly, each 4g, every day 3 times, 7 days courses of treatment, logotype 1-4 course of treatment, all stopping using, other treats in chronic pharyngitis, western drug.Follow up a case by regular visits to 1-3, the result: except that 2 examples were basic the healing, 28 examples all obtained recovery from illness.Hemogram, gastrointestinal tract etc. is not seen untoward reaction.
The specific embodiment
Embodiment: swallow refreshing particulate preparation and clinical use result slowly:
One, the refreshing particulate preparation of pharynx slowly
1, Radix Ranunculi Ternati 415g Radix Scrophulariae 415g Radix Notoginseng 249g Leptoradix Ginseng 104g.The water reflux, extract, of 5 times of amounts 3 times is filtered, and room temperature left standstill 12 hours, filtered out impurities, and vacuum concentration is the thick paste of 1.25-1.30 to relative density;
2, get Radix Notoginseng 249g Leptoradix Ginseng 104g coarse pulverization, 70-80 ℃ is ground into superfine powder, standby.
3, Xiang Shui carries in the thick paste, adds appropriate amount of auxiliary materials, mixing, and vacuum drying (temperature 60-70 ℃, vacuum 0.07-0.09Mpa) gets the about 380g of dry extract, pulverizes, and crosses 80 mesh sieves, and is standby.
4, add Radix Notoginseng, Leptoradix Ginseng's superfine powder in the above-mentioned extract powder, mixing is granulated in right amount with the 85-90% ethanol of dissolving 5g stevioside, and 60-80 ℃ is dried to water content less than 5%, put cold, approximately 1000g, pack with aluminum-plastic composite membrane, every bag of 4g approximately must 250 bags.
Two, clinical use-case:
Selection meets case 30 examples of chronic pharyngitis diagnostic criteria, takes " the refreshing granule of pharynx slowly " by the following method, and each 1 bag, one day 3 times, warm boiled water.7 days is a course of treatment, but looks 3-4 course of treatment of state of an illness logotype, and it is as follows now to enumerate some model cases:
Thank * *, the woman, 55 years old, subjective symptoms: dry pharynx, twinge, expectorant is sticking, difficulty is coughed, the foreign body in pharynx sense, feel sick uncomfortable.Through multiple Chinese and western drugs treatment, be difficult to alleviate, outbreak is 5 years repeatedly, and in July, 08, I went to a doctor PE: pharyngeal congestion, kermesinus, lymph foilicie hyperplasia, the impaired thickening of mucosa, secretions increase at institute.Took the refreshing granule of pharynx slowly 28 days, patient's clinical symptom disappearance, PE: pharyngeal nothing is obviously congested, red and swollen, and lymph follicle reduces, and does not have obvious secretions.Followed up a case by regular visits to 1 year, the state of an illness does not have repeatedly.
The week * *, the man, 28 years old, the engineer, subjective symptoms is pharyngeal to be done, itching has foreign body sensation, the pharyngeal pain of the too many sense of speech, outbreak is 2 years repeatedly, and hospital diagnosis is a chronic pharyngitis.Take the treatment by Chinese herbs poor effect.In February, 09, I went to a doctor at institute: PE: pharyngeal congestion is kermesinus, retropharyneal folliculosis, mucosal hyperplasia plumpness.Took the refreshing granule of pharynx slowly 15 days, patient's clinical symptoms is clearly better, and defence added with a course of treatment, clinical symptom disappearance, and PE: the pharynx rear wall does not have obvious hyperemia, redness, and the pharynx rear wall does not have obvious lymph follicle, and the pharyngeal mucous membrane hypertrophy is clearly better, and does not have obvious secretions.Follow up a case by regular visits to half a year, the state of an illness does not have repeatedly.
The week * *, the man, 55 years old, subjective symptoms: dry pharynx twinged, and alleviated to some extent after drinking-water is coughed, liked to the sticking difficulty of expectorant, and the normal pharyngeal sense of time-out in morning is felt sick uncomfortable.More very, through multiple Chinese and western drugs treatment, be difficult to alleviate after the smoking, showed effect repeatedly nearly 7 years, in JIUYUE, 08 comes me institute to go to a doctor PE: pharyngeal congestion, kermesinus, pharynx back lymph wall follicle hypertrophy, the enlargement of tonsil I degree, secretions increase.Took the refreshing granule of pharynx slowly 21 days, patient's clinical symptom disappearance, PE: pharyngeal nothing is obviously congested, red and swollen, and lymph follicle reduces, and does not have obvious secretions.Followed up a case by regular visits to 1 year, the state of an illness does not have repeatedly.
Old * *, the man, 30 years old, subjective symptoms: pharyngeal sense was felt sick, is retched when Chang Chenqi brushed teeth.Foreign body in pharynx sense 2 years, patient's smoking history 10 years, hospital diagnosis is a chronic pharyngitis.Take " swallowing oxazepan slowly " and treat, be difficult to alleviate through multiple Chinese and western drugs, outbreak repeatedly, in JIUYUE, 08 comes me institute to go to a doctor PE: pharyngeal mild hyperaemia, pharynx back lymph wall follicle hypertrophy, secretions increase.Took the refreshing granule of pharynx slowly 14 days, patient's clinical symptom disappearance, PE: pharyngeal nothing is obviously congested, and the pharynx rear wall does not have lymph follicle, does not have obvious secretions.Reach the clinical cure standard, followed up a case by regular visits to 1 year, the state of an illness does not have recurrence.
Claims (7)
1. a Chinese medicine for the treatment of the chronic pharyngitis disease is characterized in that being made up of following medicine and weight ratio: Radix Ranunculi Ternati 415-450 Radix Scrophulariae 415-450 Radix Notoginseng 498-665 Leptoradix Ginseng 208-400.
2. medicine according to claim 1 is characterized in that described medicine is the granule dosage form.
3. medicine according to claim 1 is characterized in that described medicine is a pill-type.
4. medicine according to claim 1 is characterized in that described medicine is a tablet form.
5. medicine according to claim 1 is characterized in that described medicine is a capsule formulation.
6. medicine according to claim 1 is characterized in that described medicine is an oral liquid formulation.
7. medicine according to claim 1 is characterized in that described medicine is the mixture dosage form.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100442400A CN101856424B (en) | 2009-09-03 | 2009-09-03 | Chinese medicament for treating chronic pharyngitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100442400A CN101856424B (en) | 2009-09-03 | 2009-09-03 | Chinese medicament for treating chronic pharyngitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101856424A true CN101856424A (en) | 2010-10-13 |
| CN101856424B CN101856424B (en) | 2011-10-05 |
Family
ID=42942728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100442400A Active CN101856424B (en) | 2009-09-03 | 2009-09-03 | Chinese medicament for treating chronic pharyngitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101856424B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103071072A (en) * | 2013-02-05 | 2013-05-01 | 刘梅生 | Chinese medicinal preparation for treating pharyngitis |
| CN104353032A (en) * | 2014-10-23 | 2015-02-18 | 王小英 | Medicated wine composition and application thereof |
| CN104940313A (en) * | 2015-07-25 | 2015-09-30 | 曹健 | Traditional Chinese medicine preparation for treating sphagitis |
| CN105194314A (en) * | 2015-10-27 | 2015-12-30 | 陈志金 | Sore-throat-relieving traditional Chinese medicine combination |
| CN106511600A (en) * | 2015-09-14 | 2017-03-22 | 张钦 | Functional food or medicine for treating chronic pharyngitis |
| CN108635565A (en) * | 2018-08-10 | 2018-10-12 | 葛介云 | A kind of pill and preparation method thereof for treating chronic pharyngitis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1220515C (en) * | 2004-02-22 | 2005-09-28 | 通化方大药业股份有限公司 | Medicine for treating throat disease |
| CN100469378C (en) * | 2005-09-07 | 2009-03-18 | 梁珍惠 | Pharmaceutical composition for treating pharyngitis |
| CN101095827B (en) * | 2007-07-03 | 2011-04-20 | 扬子江药业集团有限公司 | Chinese traditional medicine preparations for treating laryngopharynx disease and method for preparing the same |
-
2009
- 2009-09-03 CN CN2009100442400A patent/CN101856424B/en active Active
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103071072A (en) * | 2013-02-05 | 2013-05-01 | 刘梅生 | Chinese medicinal preparation for treating pharyngitis |
| CN104353032A (en) * | 2014-10-23 | 2015-02-18 | 王小英 | Medicated wine composition and application thereof |
| CN104940313A (en) * | 2015-07-25 | 2015-09-30 | 曹健 | Traditional Chinese medicine preparation for treating sphagitis |
| CN106511600A (en) * | 2015-09-14 | 2017-03-22 | 张钦 | Functional food or medicine for treating chronic pharyngitis |
| CN105194314A (en) * | 2015-10-27 | 2015-12-30 | 陈志金 | Sore-throat-relieving traditional Chinese medicine combination |
| CN108635565A (en) * | 2018-08-10 | 2018-10-12 | 葛介云 | A kind of pill and preparation method thereof for treating chronic pharyngitis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101856424B (en) | 2011-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101856424B (en) | Chinese medicament for treating chronic pharyngitis | |
| CN102357146A (en) | Traditional Chinese medicine for treating beriberi | |
| CN102579890B (en) | Chinese medicine preparation for curing vomit | |
| CN102125651A (en) | Chinese medicinal throat-disinhibiting tea for treating chronic pharyngitis | |
| CN104491356A (en) | Traditional Chinese medicine composition for treating swollen sore throat and chronic pharyngitis | |
| CN101524497A (en) | Chinese medicinal preparation for treating pharyngitis | |
| CN101745060B (en) | Chinese medicament for treating chronic bronchitis | |
| CN102274389B (en) | Chinese medicinal composition for treating chronic pharyngitis | |
| CN101371901A (en) | Orally taken Chinese medicinal composition for treating bad breath | |
| CN101129672A (en) | Orally taken traditional Chinese medicine composition for treating bacillary dysentery | |
| CN102210818B (en) | Chinese medicine for treating gastrorrhagia | |
| CN101856481A (en) | Externally used ointment for dispersing swelling and dissipating binds | |
| CN104800714A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis | |
| CN104740330A (en) | Traditional Chinese medicine oral decoction for treating chronic pharyngitis | |
| CN102091195B (en) | Medicament for treating snore and sleep apnea syndrome | |
| CN100579559C (en) | Oral Chinese-medicinal composition for treating bromopnea | |
| CN102166298B (en) | Chronic pharyngitis preparation | |
| CN104042713A (en) | Traditional Chinese medicine composition for treating bronchial asthma | |
| CN104127668A (en) | Traditional Chinese medicinal preparation for curing chronic pharyngitis | |
| CN102670713A (en) | Traditional Chinese medicine for treating oral ulcers | |
| CN114917287B (en) | Traditional Chinese medicine composition for treating allergic asthma, preparation method and application thereof | |
| CN106110285B (en) | A kind of Chinese medicine composition and its preparation and application for being used to treat the upper respiratory tract and oesophagus tract disease | |
| CN102406806B (en) | Traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung and preparation method thereof | |
| CN108186817A (en) | A kind of pill medicine for treating chronic rhinosinusitis in children and preparation method thereof | |
| CN104971237A (en) | Traditional Chinese medicine combined preparation for treating radiation esophagitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20231026 Address after: 410000 room 410, shaping Street office building, No. 1118, Zhongqing Road, shaping street, Kaifu District, Changsha City, Hunan Province Patentee after: Yang Jichang Address before: 417126 Group 11, Jiaotong Road Neighborhood Committee, Lianyuan City, Loudi City, Hunan Province Patentee before: Zhang Qin |
|
| TR01 | Transfer of patent right |